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Abstract
Haematopoiesis is the process of generation of blood cells. Lymphopoiesis gen-
erates lymphocytes, the cells in charge of the adaptive immune response. Dis-
ruptions of this process are associated with diseases like leukaemia, which is
especially incident in children. The characteristics of self-regulation of this pro-
cess make them suitable for a mathematical study.
In this paper we develop mathematical models of lymphopoiesis using cur-
rently available data. We do this by drawing inspiration from existing structured
models of cell lineage development and integrating them with paediatric bone
marrow data, with special focus on regulatory mechanisms. A formal analysis of
the models is carried out, giving steady states and their stability conditions. We
use this analysis to obtain biologically relevant regions of the parameter space
and to understand the dynamical behaviour of B-cell renovation. Finally, we
IThese authors contributed equally to this work.
Preprint submitted to Journal of Theoretical Biology July 28, 2020
ar
X
iv
:2
00
7.
13
52
6v
1 
 [q
-b
io.
TO
]  
8 J
ul 
20
20
use numerical simulations to obtain further insight into the influence of prolif-
eration and maturation rates on the reconstitution of the cells in the B line. We
conclude that a model including feedback regulation of cell proliferation repre-
sents a biologically plausible depiction for B-cell reconstitution in bone marrow.
Research into haematological disorders could benefit from a precise dynamical
description of B lymphopoiesis.
Keywords: Mathematical medicine, Haematopoiesis, Mathematical modelling,
Lymphopoiesis
2010 MSC: 92B05, 92C15
1. Introduction
Blood is a tissue under continuous regeneration, and its renovation is one
of the most studied developmental processes in biology [1]. It is initiated
by haematopoietic stem cells and develops through a multi-step differentia-
tion cascade [2], resulting in the generation of red blood cells, platelets and5
cells of the immune system. Figure 1(a) shows the standard representation of
haematopoiesis as a tree. At the top, stem cells with the potential for self-
renewal give rise to respective lineage progenitors. These cells become progres-
sively more specialised as they move towards the bottom of the tree. There are
two major cell lineages: the myeloid line and the lymphoid line. The latter gen-10
erates lymphocytes, involved in adaptive immune response, which is responsible
for ‘targeted’ reactions to infections.
In this work, we will focus on the description of B lymphopoiesis, i.e. the
development and maturation of B cells. These cells have a range of roles, being
mainly associated with the secretion of antibodies, the elements in charge of15
the neutralisation of foreign invaders [3]. Figure 1(b) shows a schematic repre-
sentation of the route from common lymphoid progenitor to immature B cells,
which eventually exit the bone marrow to complete maturation elsewhere. Al-
terations in the generation of B cells are related to diseases like autoimmune
reactions, immunodeficiencies or lymphoproliferative disorders like lymphomas20
2
or leukaemias [4]. The latter have especial incidence in children and constitute
around one third of all childhood cancer cases [5].
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Figure 1: (a) Schematic representation of haematopoiesis. (b) B-cell lineage starts from a
common lymphoid progenitor and then progresses towards immature B cells, which eventually
leave the bone marrow. Hallmarks of this process are the acquisition of the immunophenotypic
cell surface markers CD19 for the whole B line and CD10 for immature B cells.
Haematopoiesis is a perfect example of self-renewal and stemness in tissues
[6]. Mathematical descriptions have been performed using multi-compartmental,
continuously structured models [7, 8, 9]. In those models, each cell type in Fig-25
ure 1(a) can be thought of as a cell compartment that receives input from the
upper elements and sends its output to the lower compartments [10, 11, 12,
13, 14, 15, 39]. Some models have focused explicitly on the B-cell line [17, 18].
Unlike full haematopoiesis, this process is sequential, simplifying its mathe-
matical conceptualisation. The compartmental models described above become30
nonlinear when the interactions between the different cell stages are included.
Indeed, this process requires some kind of negative regulatory feedback in order
to ensure steady production [19, 20]. This feature is common in the modelling
of biological systems since they normally consist of a considerable number of
interacting components [21].35
In the case of B cells, their development depends on the joint action of a
number of factors that support or inhibit B-cell growth and differentiation [22].
A clear description of the participants at each stage of development is lacking
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[4], which is in part due to the difficulties in recreating in-vivo conditions in
experimental designs [23]. Mathematical models can help in elucidating which40
processes are more influenced by a given type of signal, as has been done for a
number of lineages and scenarios [24, 25, 26, 27, 28], and a better comprehension
of these interactions can be useful in understanding progression to malignancies
[29].
In this context, a complete picture of B lymphopoiesis would be a useful45
complement to those modelling scenarios that consider an input of B cells or that
represent B-cell-related phenomena [18, 30, 31, 32, 33]. Precise knowledge of the
dynamical behaviour of each stage of differentiation stage can also be of help
in clinical situations where disorders are especially linked to the characteristics
of the cell of origin. In leukaemias, for instance, the phenotype of the tumour50
cells is an important diagnostic criterion [34]. Our aim in this paper is thus to
develop a model of B lymphopoiesis in the bone marrow. We will construct and
investigate the properties and dynamical behaviour of a series of models. This
will be complemented with data from the literature, which mainly comes from
in-vitro assays and immune reconstitution studies, and with clinical data from55
haematological patients.
This paper is structured as follows: In Sec. 2 we explain basic haematological
models, going from a general model to a reduced family of models more suitable
for lymphopoiesis. In Sec. 3 we perform a mathematical analysis of these
models, including positivity, boundedness and stability. In Sec. 4 we carry out60
numerical simulations, taking into account clinical data and information from
the literature. In Sec. 5 we discuss these results and examine the potential
of these models to describe the process, concluding with the kind of research
opportunities that this analysis paves the way for.
2. Mathematical models and methods65
Our aim here is to describe B-cell development taking into account what the
data can tell us about the structure of the population of this haematopoietic
4
line. An illustration of the representation of cell development can be found in
[35, 36], where the authors proposed n maturation stages for a cell population
un = un(t), with t ∈ R representing time. In this case, u1 would represent70
stem cell population, un a mature specialised cell and ui (i = 2, . . . , n − 1)
intermediate stages.
The model was studied in terms of proliferation rates pi = pi(t) and the
so-called self renewal fraction ai = ai(t), for each maturation stage i = 1, ..., n.
The latter is considered to be the probability of a cell remaining in the same
cell compartment after mitosis. The authors assumed that cells at stage i en-
ter mitosis with a rate pi, resulting in a total number of 2piui after mitosis.
Then, with probability ai, they remain in the same compartment, whereas with
probability 1− ai they go on to the next maturation stage. Therefore, each cell
compartment has an output of piui and an input 2piaiui from their own com-
partment. Consequently, the previous compartment (except at the first stage)
provides the input corresponding to the number of cells that go on to the next
maturation stage after mitosis: 2pi−1(1− ai−1)ui−1. Lastly, mature cells die at
a rate d, and they are not considered to enter mitosis. If we consider n = 3
stages for stem cells (u1), intermediate cells (u2) and specialised cells (u3), the
result is the following system of equations:
du1
dt
= p1(2a1 − 1)u1, (1a)
du2
dt
= p2(2a2 − 1)u2 + 2p1(1− a1)u1, (1b)
du3
dt
= 2p2(1− a2)u2 − du3. (1c)
B cells are far from the haematopoietic stem cells since they are already com-
mitted to the B line, thus losing part of their potential for self-renewal. We then
choose to specify cell behaviour in each compartment in terms of proliferation75
and maturation, i.e. progression to the next stage, and to restrict the system to
three different cell compartments, considering the most common immunophe-
notypical characterisation used in clinical practice [37]. The first compartment
would also receive input from previous lymphoid progenitors. However, this
5
early compartment is smaller and thus a constant source term contribution80
would be less significant [38]. Furthermore, this input is also regulated, which
would require adding an equation from the previous compartment, and simi-
larly for even earlier compartments. Our aim was to restrict the analysis to the
CD19+ fraction of the B-cell line, as suggested by the data (see Appendix A).
Thus we will consider three compartments accounting for the different matu-
ration stages: early B cells (C1 = C1(t)), intermediate B cells (C2 = C2(t)), and
finally late B cells (C3 = C3(t)), where t ∈ R represents time. A compartmental
model can then be written as
dC1
dt
= ρ1C1 − α1C1, (2a)
dC2
dt
= ρ2C2 + α1C1 − α2C2, (2b)
dC3
dt
= α2C2 − α3C3. (2c)
Note that this formulation is equivalent to the model from Eq. (1) with85
ui = Ci for i = 1, 2, 3 and parameters ρi = pi, αi = 2pi(1− ai) for i = 1, 2, and
α3 = d.
Early B cells, described here by Eq. (2a), have a proliferation rate ρ1 and
a transition rate into intermediate B cells of α1. Analogously, the proliferation
rate for intermediate B cells and transition rate into the late compartment are90
ρ2 and α2, as described in Eq. (2b). In this equation, a fraction of α1C1 cells
comes from the early B compartment. This also happens with the α2C2 cells
that change their phenotypes from the intermediate B-cell into the late B-cell
compartment. Late B cells in Eq. (2c) are not considered to enter mitosis and
they go into the blood flow with a blood transition rate α3.95
This compartmental model needs to be complemented with a regulatory
system involving cell feedback signalling s(t). Different types of signalling and
the importance of the regulation of self-renewal in homeostatic (steady) state
have been previously studied in the literature [14, 19, 20, 24, 25, 26, 27]. In our
case, there are different ways of specifying which cells participate in signalling100
and through which processes. In this paper we consider two different hypotheses.
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The first is that signals are produced either by late cells (model 1) or by all
cells (model 2). The second is that signals can alternatively affect either the
proliferation rate (model A) or the transition rate of the model (model B).
Therefore, we will consider four possibilities regarding feedback signalling. This105
is summarized in Figure 2.
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Figure 2: Representation of the different feedback signalling possibilities. (a) The signal may
be produced by the most mature cells and then affect the previous compartments (model 1);
or it may be produced by all cells, influencing the whole population (model 2). (b) Signalling
can alternatively affect either the proliferation rate (model A) or the transition rate (model
B).
As stated in the introduction, the precise number and role of interacting
elements is unclear. The basic immune system chemical messengers are the
cytokines, proteins that control cell production. They can be generated by
microenvironmental elements but also from cells themselves [40]. For B cells,110
a number of cytokines have been shown to be relevant: IL-7 for proliferation,
differentiation (transition) and survival [41], and SCF and FLT3LG [42] for pro-
liferation of early stages [43]. Evidence in this regard comes mainly from in-vitro
and murine models and differences with humans can be significant [23]. Due to
this uncertainty and complexity we decided to follow an implicit formulation for115
the signalling as in [18], where instead of including each contributor explicitly
we consider the systemic action of each, and gather them together in a single
function s(t).
With respect to the form of this signalling function s(t), we follow the de-
velopment set out in [35]. First, let us consider a maximal signal ρS , which is
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self-limited with rate αS . Consider then a number of cells N = N(t) that regu-
lates the production of this signal in such a way that it decreases when there is
a large number. Thus, a general signalling S = S(t) can be modelled as
dS
dt
= ρS − αSS − βSN, (3)
where β is the inhibitory influence of cells N . By making a change of variables
s(t) = αS/ρS · S(t) and k = β/αS , we obtain a differential equation whose
quasi-steady state is s(t) = 1/(1 + kN(t)). A rigorous analysis of this quasi-
steady state approximation can be found in [44]. Signal concentration depends
on the number of cells of type N . Following the explanation in Figure 2 we will
consider the case when only the late cells participate in signalling, i.e.
s1(t) =
1
1 + kC3
, (4)
or the case where all cells participate
s2(t) =
1
1 + k
∑3
i=1 Ci
. (5)
Note that s(t) is a decreasing function of the cell numbers Ci so it has an in-
hibitory role. The parameter k measures the strength of the inhibitory feedback.120
To sum up, we will consider the models:
dC1
dt
= sρρ1C1 − sαα1C1, (6a)
dC2
dt
= sρρ2C2 + sαα1C1 − sαα2C2, (6b)
dC3
dt
= sαα2C2 − sαα3C3. (6c)
Feedback signalling affects either proliferation (signal sρ = sρ(t)) or transition
rates (signal sα = sα(t)). The form of the signals sρ, sα depends on the signalling
source, either s1(t) or s2(t). This yields four possible models, summarised in
Table 1.
8
Signalling 1. Late cells 2. All Cells
A. Affecting proliferation Model A1 Model A2
(sρ = s1, sα = 1) (sρ = s2, sα = 1)
B. Affecting transition Model B1 Model B2
(sρ = 1, sα = s1) (sρ = 1, sα = s2)
Table 1: Mathematical models considered depending on signalling.
3. Theoretical results125
3.1. Existence, boundedness and positivity of solutions
Models A can be written as
dC1
dt
=
ρ1C1
1 + kN
− α1C1, (7a)
dC2
dt
=
ρ2C2
1 + kN
+ α1C1 − α2C2, (7b)
dC3
dt
= α2C2 − α3C3, (7c)
and models B have the form
dC1
dt
= ρ1C1 − α1C1
1 + kN
, (8a)
dC2
dt
= ρ2C2 +
α1C1
1 + kN
− α2C2
1 + kN
, (8b)
dC3
dt
=
α2C2
1 + kN
− α3C3
1 + kN
. (8c)
Feedback signalling can depend on cells from the late stage with N = C3 (models
A1 and B1 with signal s1(t) as in Eq. (4)) or on all cells with N =
∑3
i=1 Ci
(models A2 and B2 with signal s2(t) as in Eq. (5)).
Theorem 1. Let us consider the following set
Q = {(C1, C2, C3) ∈ R3 : C1, C2, C3 > 0}, (9)
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and the initial values in Q
C1(t0) = C
0
1 , C2(t0) = C
0
2 , C3(t0) = C
0
3 , (10)
Then, the initial value problem for either Eqs. (7) or Eqs. (8) has a unique130
local-in-time solution for each t ∈ [t0 − , t0 + ], for some value  > 0.
Proof. The existence of a solution for systems from Eq. (7) and Eq. (8) is
guaranteed for each (C1, C2, C3) ∈ Q by continuity of the functions
fρ1 = f
ρ
1 (C1, C2, C3) =
ρ1C1
1 + kN
− α1C1, (11a)
fρ2 = f
ρ
2 (C1, C2, C3) =
ρ2C2
1 + kN
+ α1C1 − α2C2, (11b)
fρ3 = f
ρ
3 (C1, C2, C3) = α2C2 − α3C3, (11c)
and
fα1 = f
α
1 (C1, C2, C3) = ρ1C1 −
α1C1
1 + kN
, (12a)
fα2 = f
α
2 (C1, C2, C3) = ρ2C2 +
α1C1
1 + kN
− α2C2
1 + kN
, (12b)
fα3 = f
α
3 (C1, C2, C3) =
α2C2
1 + kN
− α3C3
1 + kN
, (12c)
where again N = C3 or N =
∑3
i=1 Ci. Boundedness of the respective partial
derivatives of fαi and f
ρ
i for i = 1, 2, 3 proves that they satisfy the Lipschitz
conditions, and therefore the solutions of systems from Eq. (7) and Eq. (8)
with initial values as in Eq. (10) are unique by the Picard-Lindelo¨f theorem.135
Henceforth we will consider that all parameters ρi, αi and initial conditions
C0i are positive for i = 1, 2, 3.
Theorem 2. The solutions of Eqs. (7) and Eqs. (8) with (C01 , C
0
2 , C
0
3 ) ∈ Q are
positive.
Proof. Let us consider the functions fρi , f
α
i with i = 1, 2, 3 from Eqs. (11) and
Eqs. (12), respectively. As fρi , f
α
i > −αiCi, we know that
dCi
dt
> −αiCi. (13)
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By integrating both sides of the equation from t0 to t we obtain
Ci(t) > C
0
i exp(−αit) > 0. (14)
And therefore all solutions Ci(t), i = 1, 2, 3 are positive over their domain of140
definition.
Theorem 3. The solutions C1(t), C2(t), C3(t) of Eqs. (7) with (C
0
1 , C
0
2 , C
0
3 ) ∈
Q are bounded.
Proof. In model from Eq. (7) if we consider C1 to be unbounded, then
lim
C1→∞
dC2
dt
=∞, (15)
which would imply that C2 would also be unbounded, and analogously for the
case of C3. We could then write
lim
Ci→∞
Ci
1 + kC3
= lim
Ci→∞
Ci
1 + k
∑3
j=1 Cj
=
1
k
for i = 1, 2, 3. (16)
Let us now consider the functions fρi from Eq. (11). From Eq. (16) we get
fρ1 <
ρ1
k
− α1C1, (17)
and then for all t
C1 < Ae
−α1t +
ρ1
kα1
, A ∈ R, (18)
which yields that C1(t) is bounded. Considering C1(t) < M1 ∈ R, for all t, then
fρ2 <
ρ2
k
+ α1M1 − α2C2, (19)
and integrating as above implies C2 is bounded. Considering C2 < M2 ∈ R,
fρ3 < α2M2 − α3C3, (20)
and thus C3 is also bounded.
For the models B, ruled by Eqs. (8), we can sum the three equations to
obtain
dCT
dt
= ρ1C1 + ρ2C2 − α3C3
1 + kN
, (21)
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where CT = C1 + C2 + C3. It is clear that for C1 and C2 sufficiently large145
the negative term makes only a small contribution and thus solutions are not
bounded. This implies that models in which signalling affects only transition
rates are not appropriate for representing biological processes of this kind.
3.2. Steady States and stability conditions
Biological processes in homeostasis are stable and robust. In addition to150
being mathematically well posed, we need to ensure that the models have a
positive stable equilibrium in which the three populations coexist. In this section
we study the existence of such states and their local stability. We focus on
models A (Eq. (7)), since models B (Eq. (8)) do not lead to biologically
relevant dynamics. An expanded analysis of the stability conditions for certain155
steady states of models A can be found in Appendix B. Further analysis of
models B, showing that they have only unstable non-trivial positive equilibria,
is presented in Appendix C.
3.2.1. Model A1
Let us consider last stage signalling sρ = s1(t) as in Eq. (4) affecting the
proliferation term, i.e. we study Eq. (7) with N = C3. The three steady states
for this model are
PA11 = (0, 0, 0), (22a)
PA12 =
(
0,
α3(ρ2 − α2)
kα22
,
ρ2 − α2
kα2
)
, (22b)
PA13 =
(
α3(ρ1 − α1)(α2ρ1 − α1ρ2)
kα21α2ρ1
,
α3(ρ1 − α1)
kα1α2
,
ρ1 − α1
kα1
)
. (22c)
The Jacobian matrix of the system at any point (C1, C2, C3) is
JA1(C1, C2, C3) =

ρ1
C3k + 1
− α1 0 − C1kρ1
(C3k + 1)2
α1
ρ2
C3k + 1
− α2 − C2kρ2
(C3k + 1)2
0 α2 −α3
 . (23)
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Substituting PA11 = (0, 0, 0) in Eq. (23) we get the eigenvalues
λA11,1 = −α3, (24a)
λA11,2 = ρ1 − α1, (24b)
λA11,3 = ρ2 − α2. (24c)
This is the trivial equilibrium that would be unstable in normal homeostatic
processes. Instability conditions are
ρ1 > α1, or ρ2 > α2. (25)
As we consider PA12 > 0, it must be ρ2 > α2, and therefore P
A1
1 is unstable.160
For PA12 , we obtain
λA12,1 =
α2ρ1
ρ2
− α1, (26a)
λA12,2 = −
α3
2
−
√
α3(4α22 − 4α2ρ2 + α3ρ2)
2
√
ρ2
, (26b)
λA12,3 = −
α3
2
+
√
α3(4α22 − 4α2ρ2 + α3ρ2)
2
√
ρ2
. (26c)
This equilibrium point corresponds to a situation where the less differentiated
compartment disappears and the system is maintained only by the proliferation
of the second, leading to mature cells. As before, this is not a biologically
feasible situation, thus this equilibrium must be unstable. Since R(λ2,2) < 0
and R(λ2,3) < 0, then α2ρ1ρ2 − α1 > 0, which means that for PA12 to be unstable
we must have
α2ρ1 − α1ρ2 > 0. (27)
From the positivity of the non-trivial equilibrium point PA13 we require
ρ1 > α1, (28a)
ρ1
ρ2
>
α1
α2
. (28b)
Conditions (28b) and (27) are identical which means that the existence of this
positive equilibrium implies the instability of PA12 . Stability conditions for P
A1
3
are lengthy and can be found in Appendix B.
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3.2.2. Model A2
Model A2 is given by Eqs. (7) with N =
∑3
i=1 Ci. The equilibria are
PA21 = (0, 0, 0), (29a)
PA22 =
(
0,
α3(ρ2 − α2)
kα2(α2 + α3)
,
ρ2 − α2
k(α2 + α3)
)
, (29b)
PA23 =
(
α3(ρ1 − α1)(α2ρ1 − α1ρ2)
α1kβ
,
α3ρ1(ρ1 − α1)
kβ
,
α2ρ1(ρ1 − α1)
kβ
)
, (29c)
where
β = (α2α3ρ1 + α1(α2ρ1 + α3(ρ1 − ρ2))) . (30)
The Jacobian matrix is
JA2 =

−α1 + (s−1 − kC1)s2ρ1 −C1ks2ρ1 −C1ks2ρ1
α1 − C2ks2ρ2 −α2 + (s−1 − kC2)s2ρ2 −C2ks2ρ2
0 α2 −α3
 .
(31)
Substituting PA21 in Eq. (31) we obtain
λA21,1 = −α3, (32a)
λA21,2 = ρ1 − α1, (32b)
λA21,3 = ρ2 − α2. (32c)
As before, for this equilibrium to be unstable we should have either ρ1 > α1165
or/and ρ2 > α2. From the positivity of P
A2
2 , it must be the case that ρ2 > α2.
For PA22 , we obtain the eigenvalues
λA22,1 =
α2ρ1
ρ2
− α1, (33a)
λA22,2 =
α22α3 − 2α2α3ρ2 − α23ρ2 + h(α2, α3, ρ2)
2ρ2(α2 + α3)
, (33b)
λA22,3 =
α22α3 − 2α2α3ρ2 − α23ρ2 − h(α2, α3, ρ2)
2ρ2(α2 + α3)
. (33c)
where h = h(α2, α3, ρ2) such that
h =
√
α3
√
2α22α3(α3 − 2ρ2)ρ2 + 4α32(α3 − ρ2)ρ2 + α33ρ22 + α42(α3 + 4ρ2). (34)
14
As in the previous model, the existence of PA23 as a positive equilibrium
influences the stability of PA22 . For the positivity of P
A2
3 we have a first set of
conditions
β > 0, (35a)
ρ1 > α1, (35b)
α2ρ1 > α1ρ2; (35c)
or a second set of conditions
β < 0, (36a)
ρ1 < α1, (36b)
α2ρ1 < α1ρ2. (36c)
Let us first consider that Eq. (35) holds. Then, in Eq. (33), the eigenvalue λA22,1
is positive and PA22 would be unstable. On the other hand, if Eq. (36) holds,
then in Eq. (33) the eigenvalue λA22,1 < 0. Then P
A2
2 would be stable whenever
|R(h)| > α22α3 − 2α2α3ρ2 − α23ρ2 (37)
for h as defined in Eq. (34).
In this case, for the stability of PA22 , the difference with model A1 is the
existence of a denominator β (Eq. (30)). The stability conditions for PA23
are not shown here for reasons of space, but they are presented in Appendix170
B. Stability conditions related to model B, as well as a summary of all the
stability conditions depending on both models, can be found in Appendix C
and Appendix D, respectively.
4. Numerical results
4.1. Parameter estimation175
In the models presented above there are two parameters related to prolifer-
ation ρi (i = 1, 2), three related to compartmental transitions αi (i = 1, 2, 3),
and another related to the strength of signalling, the inhibition constant k.
15
A direct measure of the proliferation rates for the specific subsets considered
in this paper is lacking, but we can provide an estimation based on qualitative180
biological information. Normal B-cell development can be compared to data
from autologous bone marrow transplantation. This type of transplantation is
more likely to reproduce developmental ontogeny, especially if there is no prior
or coadjuvant anti-B-cell therapy [45]. In this case B-cell progenitors can be
detected in bone marrow as early as 1 month after transplantation [46, 47], and185
in blood after some delay [48]. In-vitro studies with mice show that proliferation
rates are of the order of magnitude of days [40, 49, 50]. Human lymphoid
cultures suggest doubling times of 1 day [51]. With respect to the relative values,
current schemes for B-cell maturation indicate that upon CD19 acquisition there
is sustained proliferation that decreases as the cell matures [40, 52, 53]. Late190
B cells already express B-cell receptor and a negative selection process occurs
prior to this [22, 54]. Based on this we can consider that the net production
rate of intermediate cells is lower than early cells (ρ1 > ρ2).
In order to obtain values for transition rates we make use of steady state
expressions given by (22c) or (29c). These values can be compared to the flow
cytometry data of normal bone marrow (See Appendix A). However, in our
simulations we are measuring absolute cell counts while flow cytometry is only
able to measure relative cell proportions. The positive non-trivial equilibrium
(C∗1 , C
∗
2 , C
∗
3 ) given by (22c) or (29c) satisfies the relationships
C∗2
C∗3
=
α3
α2
, (38a)
C∗1
C∗2
=
α2ρ1 − α1ρ2
α1ρ1
. (38b)
These quantities can be obtained from the analysis of the relative abundance
of the three different populations. Thus, for each blood transition rate α3 we195
can obtain values of α1, α2 that agree with steady-state data and at the same
time belong in the positive stability region of parameter space. An example
of the correlation found between transition rates is shown in Figure 3. The
order of magnitude of α3 can be estimated as follows. The term α3C
∗
3 gives
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the total number of B cells per hour sent to blood by the bone marrow in200
homeostatic circumstances. In mice, bone marrow produces around 0.1% of
the steady state population per hour [55]. In humans, the total steady-state
B-lymphocyte population can be obtained from lymphocyte proportions and
bone-marrow volumes from the literature and we estimate it to be 1010 cells
[56, 57, 58, 59, 60]. This yields a B-cell production of 107 cells per hour, and205
given that C∗3 ∼ 109 we estimate α3 to be of the order of magnitude of 10−2 h−1.
Figure 3: Dependence of the transition rates over the range of stability. Lines represent α1
(light purple solid line), α2 (purple dashed line), α3 (dark purple dotted line). Across this
range αj satisfies the relationship α3 > α1 > α2. Values computed from Eq. (38) with
ρ1 = 0.0289 h
−1, ρ2 = 0.0193 h−1 and steady-state cell proportions C∗1/C
∗
2 = 0.0986 and
C∗2/C
∗
3 = 3.227.
The last parameter to be determined is the inhibition constant k. Inspection
of steady states shows that, given transition and proliferation rates of the order
of magnitude of days, k is of the order of magnitude of the inverse of the total
steady-state population k ∝ (C∗1 + C∗2 + C∗3 )−1. The precise values for k and210
α3 are selected so that we recover steady-state values and reconstitution times
compatible with the literature cited above. Ranges of parameters in agreement
with positivity, stability and steady-state conditions are shown in Table 2.
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Param. Meaning Value Units
ρ1 Early B proliferation rate ln(2)/24 hours
-1
ρ2 Intermediate B proliferation rate ln(2)/36 hours
-1
α1 Transition rate: early to intermediate (0.004, 0.025) hours
-1
α2 Transition rate: intermediate to late (0.003, 0.02) hours
-1
α3 Transition rate: late to blood (0.01, 0.065) hours
-1
k Inhibition constant (10−11, 10−10) cells-1
Table 2: Parameter values for Eqs. (7).
With respect to the initial state, the absolute number of mononucleated
transplanted cells (MNC) is in the range of 109 cells [48]. From these cells,215
only a 1% are B early cells (107 cells) [38, 61]. These cells travel through blood
into the bone marrow but only 10% of cells eventually reach the bone marrow
[62]. Therefore, we will consider for the numerical simulations of autologous
transplantation an initial absolute number of cells of C1(0) = 10
6, C2(0) = 0,
C3(0) = 0. The influence of this initial value on the dynamics of the system is220
described in Sec. 4.3.
4.2. Global feedback signalling results in a smoother transition to steady states.
Typical results of simulations of models A1 and A2 (Eq. (7)) are shown in
Figure 4. Recall that in model A1 (Figure 4(a)) the signal depends only on cells
in the final compartment while in model A2 (Figure 4(b)) all cells are involved.225
Both models exhibit qualitatively similar behaviour. Early cells appear first,
reaching a peak in population numbers slightly before day 30. Intermediate
cells follow, reaching the respective peak with days of delay and with larger
cell numbers. Late cells appear last and stabilize in between. The system
settles into the steady state from day 80 onwards. This behaviour agrees with230
the conditions expressed above for the parameter values. In particular, the
proportion of population from each stage is coherent with clinical data (See
Appendix A) and experimental data [38]. For both models we have 8.99%
early cells, 70.21% intermediate cells and 20.80% late cells.
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Figure 4: Comparison of numerical solutions of models A1 (a) and A2 (b) (Eq. (7)) and
relative proportions (c) and (d), respectively, during the first 100 days. Curves represent
early cells C1 (dark blue solid line), intermediate cells C2 (blue dashed-dotted line) and late
cells C3 (light blue dashed line). Both simulations have initial data C1(0) = 106, C2(0) = 0,
C3(0) = 0 cells and parameter values ρ1 = 0.0289 h
−1, ρ2 = 0.0193 h−1, α1 = 0.008 h−1,
α2 = 0.006 h
−1, α3 = 0.02 h−1 and k = 10−10.
There are two main differences between the two models. The first relates to235
the magnitude of the steady state, which is larger when only late cells participate
in signalling (model A1, Figure 4(a)) for the same parameter values. This can
be observed in Figure 5(a), where total cell numbers for both models are shown.
Note that peak lymphocyte count, i.e. the largest cell number, occurs at day
30, when intermediate cells are maximal. The second difference relates to the240
19
early behaviour of the reconstitution. In global signalling simulation (model
A2, Figure 4(b)) there is a much less pronounced peak than when only late
cells perform the signalling, presenting a smoother transition to the equilibrium
state.
Figures 4(c) and (d) show the evolution of the percentage of each maturation245
stage. It is interesting to relate this to absolute counts since, as explained
in Sec. 4.1, flow cytometry data only captures relative cell proportions. We
observe very close behaviour between the models. The percentage of early cells
quickly decreases as more mature stages appear and steady-state proportions
are reached from day 80 onwards. Note that even though intermediate and250
mature cells have a peak in absolute cell count, this peak is not represented in
terms of percentage. Also, this figure shows that a decrease in cell percentage
does not necessarily means a decrease in absolute cell count, something to take
into account when interpreting longitudinal flow cytometry data.
Figure 5: Comparison of numerical simulations of model A1 (orange solid line) and A2 (red
dashed line) from Eq. (7) for: (a) total number of cells C1 + C2 + C3, with initial cell
numbers C1(0) = 106, C2(0) = 0, C3(0) = 0; (b) time to peak lymphocyte count as a function
of initial early B cell number. Both simulations have parameter values ρ1 = 0.0289 h
−1,
ρ2 = 0.0193 h
−1, α1 = 0.008 h−1, α2 = 0.006 h−1, α3 = 0.02 h−1 and k = 10−10.
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4.3. Time to peak decreases exponentially with initial value255
In Sec. 4.1 we described the rationale for the choice of the initial value of
early cells. Despite this, we sought to determine how the scale of this data
impacted reconstitution times. In Figure 5(b) we show the time to peak cell
count for a range of initial values for early cells. There exists a decreasing ex-
ponential relationship between the two magnitudes, although the delay is not260
significant when considering that the literature on reconstitution after autolo-
gous transplantation describes reconstitution times in the range of 1-2 months
[46]. Multiplying initial cell numbers by 10 results in a displacement in time of
5 days.
4.4. Blood transition rate influences time to bone marrow reconstitution265
Clinical data suggests that homeostatic bone marrow displays relatively con-
stant subset proportions (See Appendix A). This, together with the analysis of
the expressions of the steady states allowed us to derive a connection between
the three transition rates in the model (Eq. 38). For the ranges of parameters
considered, we observed that α3 > α1 > α2 (see Figure 3), which suggests that270
the second compartment being more numerous could be due not to a higher
proliferation rate but rather to a slower maturation time. This calls for the
analysis of the influence of transition rates on the dynamics of the system.
In order to do this we focused on variations of α3, the rate at which late
cells exit bone marrow and enter the blood flow. We select a range of variation275
that lies in the positive stability region and observe the qualitative differences
in the immune reconstitution. Results are shown in Figure 6(a).
We observe that an increasing blood transition rate means that the system
reaches a lower number of total cells. Indeed, Eq. (22) shows that population
levels depend on transition rates. Note that the peak during reconstitution280
also decreases. In order to quantify this reduction, we show, in Figure 6(b),
the proportion of the height of the peak with respect to the final steady state,
for the same range of values for α3. For lower values of blood transition rate,
the transitory population of lymphocytes can be 1.3 times the population in
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Figure 6: Numerical simulations for variable blood transition rate. (a) Total cell number
C1 + C2 + C3 for t ∈ [0, 100] days. Blood transition rate values: α3 = 0.03 h−1 (solid line),
α3 = 0.04 h
−1 (dashed line), α3 = 0.05 h−1 (dashed-dotted line), α3 = 0.06 h−1 (dotted
line). Line colour goes from dark red to pink as blood transition rate increases. (b) Peak
to steady state value ratio for the same range of blood transition rates. Both simulations
belong to model A2 (Eq. (7)) with initial state C1(0) = 106, C2(0) = 0, C3(0) = 0 cells and
parameter values ρ1 = 0.0289 h
−1, ρ2 = 0.0193 h−1 and k = 10−10. Parameters α2 and α1
vary with α3 according to Eq. (38).
homeostatic conditions. This proportion decreases if cells increase the rate at285
which they join blood flow. Another consequence coming from these numerical
simulations is that the lower the transition rates, the longer it takes for the
system to stabilise.
4.5. Inhibition constant has no qualitative impact on the dynamical process
Eq. (22) shows that steady state values depend on transition rates (see also290
Figure 6) but also on the inhibition constant k. To quantify the impact of the
parameter k on the dynamics of the system, we computed the total steady-state
cell number as well as the proportion of peak height to steady state in a range
of α3 (and thus α1 and α2) and k values. The results are shown in Figure 7 for
model A2. With respect to the absolute final cell count, only low levels of both295
k and α3 result in a much higher number of cells. We highlighted an area for
which the total cell amount CT is in the range (10
10, 1011), as estimated in Sec.
22
4.1 from reference values. For the proportion of peak height to steady state,
there is little variation in the direction of k, so signalling intensity has little
influence on the dynamics. As shown in Figure 6, high peak values belong in300
the low blood transition rate area. We conclude that transition rates primarily
cause the overshoot during reconstitution, while k is mainly responsible for the
existence of stability regimes and the size of the final states.
Cell number(a) Peak/steady state(b)
Figure 7: Influence of inhibition constant k and blood transition rate α3 parameters in model
A2 (Eq. (7) with all cell signalling) for (a) total steady state cell number, (b) peak vs steady
states ratio. The dashed highlighted area represents the range in which total cell number
CT ∈ (1010, 1011). Each coordinate is the result of a numerical simulation of model A2 with
initial state cell numbers C1(0) = 106, C2(0) = 0, C3(0) = 0 and parameter values ρ1 =
0.0289 h−1 and ρ2 = 0.0193 h−1. Parameters α1 and α2 vary with α3 ∈ (0.01 h−1, 0.03 h−1)
as explained in Eq. (38).
5. Discussion and conclusions
Haematopoiesis is one of the most widely studied biological developmental305
processes [1]. Interesting questions arise related to the processes of cell lineage
specification [2, 63], the role of stem cells [6, 64] and the way cells communi-
cate to regulate and ensure steady production [65, 66]. This is also true for
B lymphopoiesis, the branch of haematopoiesis pertaining to B-cell formation.
Specific unknowns in B-cell biology are the origins of some developmental stages,310
the role of senescence or the array of cytokines that regulates this process [67].
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Studies of human B lymphopoiesis are encouraged, given that most of our knowl-
edge about this line comes from mouse models [4]. Answering these questions
and obtaining a precise description of the dynamics of B-cell maturation are
fundamental for research avenues. Some examples are the characterisation of315
haematological malignancies, the reconstitution after bone marrow transplant
or chemotherapy or the generation of new lymphocytes from human embryonic
stem cells [67].
Mathematical models have the potential to integrate biological hypotheses
and clinical data in order to provide an abstract representation of biological320
processes [11]. This representation can be useful not only for understanding
the dynamical properties of the system, but also for testing and elucidating
more inaccessible phenomena. Our goal in this paper was to establish a biolog-
ically sensible mathematical characterization of the B lymphopoiesis. Spurred
by previous models of haematopoietic processes [14, 35], we designed four mod-325
els each with three differentiation stages. We added an implicit and systemic
consideration of cell feedback signalling resulting in four nonlinear models. We
first analysed these models from a theoretical perspective, addressing existence,
positivity, boundedness and local stability. We collected data from the liter-
ature and clinical data from haematological patients and then used numerical330
simulations in order to understand the role and influence of each parameter.
We learn from theoretical analysis that a stable, homeostatic situation can-
not arise solely by regulating the transition rate, i.e. the process of differen-
tiation or maturation to the next compartment. We have focused from there
onward on feedback regulation of cell proliferation. Inspection of the steady335
states allowed us to use flow cytometry data to establish a relationship between
the three transition rates, analysing their influence by manipulating them one
by one. The relationship suggests that, for the specific cell proportions in the
B line, cells transition faster from early to intermediate than from intermediate
to late. Intermediate cells could then be more numerous not because they pro-340
liferate more, but because of their slower transition rates downstream towards
more mature cell types. Also, numerical simulations show that cell proportion
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is independent of which cells perform the signalling.
In this sense, we observed that signalling coming from all stages results in
a smoother reconstitution of the B cell line. Indeed, when all populations par-345
ticipate in signalling, their influence occurs earlier and proliferation decreases
faster with time than when only late cells do. In this case we observed a peak
that we understood as a consequence of the delay in the reaction of the system
to overpopulation. The amplitude of this peak is also correlated with lower
transition rates, which implies lower steady states values. This is biologically350
understandable: the late compartment saturates due to excessive input from
previous compartments, delaying access to stability and thus maintaining cell
production in upstream compartments. It is important to remark here that
subset percentage, a common metric in follow-up samples in a clinical context,
can be misleading when dynamics of expansion are at play. For example, the355
overshoot during early reconstitution is not observed in terms of relative pro-
portions. Finally, we noted that the strength of the signalling has no impact
on the dynamics. The feedback loop could then be understood as a mecha-
nism for the existence of stable output, while dynamical characteristics (time to
reconstitution or early peak) are more dependent on intrinsic cellular processes.360
The idea of this study was to determine which conditions are sufficient, from
a mathematical perspective, to represent the kind of biological data that is cur-
rently available for B-line development. While we obtain a behaviour that fits
with the time scales of the in-vivo process [45, 46, 47, 48, 51, 38], our study has a
series of limitations. Firstly, the choice of three compartments could be refined365
or expanded following a more detailed characterisation of the cells. Multidi-
mensional flow cytometry data shows that surface markers, those that specify
to which stage a given cell belongs, vary continuously. A mathematical model
where these markers vary continuously might be able to capture this variation.
Secondly, we described signalling as a systemic phenomenon. While this was370
enough to recapitulate known B-cell behaviour, a more detailed description in-
cluding two or more types of signalling is desirable. Lastly, the model would
benefit from longitudinal data coming from immune reconstitution of the B-cell
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line. In this regard, flow cytometry analyses of both peripheral blood and bone
marrow in routine follow-up would allow for a more precise parameterisation375
and enable the hypotheses presented above to be contrasted.
To conclude, we have constructed and studied several non-linear compart-
mental models describing B cell lymphocyte reconstitution. These simple mod-
els describe the process of B-cell generation as portrayed by bone marrow data,
and we consider it a first step in a deeper exploration of the phenomena associ-380
ated with B-cell development. We verified mathematical and biological consis-
tence, opening the door to interesting mathematical research like the existence
of bifurcations or the conditions for global stability, something that finds im-
mediate application in cases of immune reconstitution. Studies of this kind can
function as a source of hypothesis generation in biomedical research, for example385
when contrasting mouse versus human dynamics. Ultimately, we aim to extend
the methodology to situations of stability disruption and abnormal growth like
B-cell disorders and other haematological diseases.
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Appendix A. Data
Appendix A.1. Patients
Bone marrow samples from six individuals of paediatric age (1 to 13 years)
were used to estimate cell subset proportions. Four patients diagnosed with
Idiopathic Thrombocytopenic Purpura (1 from Jerez Hospital and 3 from Nin˜o400
Jesu´s Hospital) and two patients with neutropenia (Jerez Hospital). Due to the
difficulty in obtaining healthy bone marrow samples from patients of paediatric
age, we selected the above as surrogate examples of normal B-cell development.
Bone marrow samples were extracted from these patients in order to check
for more severe disorders, but they were later diagnosed with B cell-unrelated405
diseases. Sample inspection further ensured lack of B-line affection. Instances
of this can be found in the literature [68, 69].
Appendix A.2. Flow Cytometry
Bone marrow samples were analysed by flow cytometry. This technique
measures the expression of the immunophenotypic markers that characterise410
each maturation stage. Marker expression for both hospitals’ data was acquired
on a FACSCanto II flow cytometer following the manufacturer’s specifications
Becton Dickinson (BD) for sample preparation. Samples were stained using an
8-colour panel consisting of the following six fluorochrome-conjugated antibodies
provided by BD: CD38 FITC/ CD10 PE/ CD34 PerCP-Cy5-5/ CD19 PE-Cy7/415
CD20 APC/ CD45 V-450. This panel allows for the identification of B cell
subpopulations [34]. Forward (FSC) and side scatter (SSC) were also measured.
Samples were preprocessed removing debris, doublets and marginal events
as is routinely done in clinical and computational flow cytometry [70]. CD19+
cells were then gated in order to select B lymphocytes [71]. Since the model420
consists of three B cell populations, we performed k-means clustering on each
sample, including all B cell markers, with 3 predefined clusters. The algorithm
was initialised randomly and 100 random sets were generated, selecting the one
with lower within-cluster variation. Following standard immunophenotyping of
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B cells [37], clusters were classified into early (CD45-/CD10+), intermediate425
(CD45+/CD10+) or late (CD45+/CD10-) B cells. Proportions were then com-
puted with respect to the total B lymphocyte count (CD19+ population), which
correlates with experimental data [38]. Figure A.8 shows the three stages of the
process. All computations were carried out in RStudio using packages flowCore
[72] and flowPeaks [73].430
Figure A.8: (a) B Lymphocyte selection in grey (CD19+ population). Y-axis represents
cellular complexity, which is low for lymphocytes, and X-axis represents B Lymphocyte surface
antigen CD19. (b) Within B population, three clusters were found corresponding to three
maturation stages: early, intermediate and late populations. As B cells mature, they gain
expression of CD45 antigen and lose expression of CD10 antigen [37]. (c) Boxplots with
proportions of each maturation stage from 6 patients displaying mean and 1st and 3rd quartile.
Mean values with standard deviations: 0.083± 0.009, 0.648± 0.145, 0.268± 0.192.
Appendix B. Stability analysis for non-trivial equilibria in model A
Appendix B.1. Model A1
We recall the model from Section 3.2.1. From Eq. (22) we obtained the
steady states PA1i for i = 1, 2, 3.
Let us consider stability for the equilibrium point PA23 . We obtain the char-
acteristic equation
λ3 + b2λ
2 + b1λ+ b0 = 0, (B.1)
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where
b2 = α2 + α3 − α1ρ2
ρ1
, (B.2a)
b1 = α3
(
α2 − α
2
1ρ2
ρ21
)
, (B.2b)
b0 =
α1α3(α1 − ρ1)(α1ρ2 − α2ρ1)
ρ21
. (B.2c)
Using the Routh-Hurwitz Criterion, for PA13 to be positive and stable we must
have
b2b1 − b0 > 0, b2 > 0, b0 > 0. (B.3)
The positivity conditions found in Eq. (28) yield b0 > 0, b2 > 0. Furthermore,
the stability condition b2b1 − b0 > 0 is satisfied if ρ1 ≤ ρ2. If ρ1 > ρ2, the
stability criterion is equivalent to satisfying either
α21ρ2 ≤ ρ1(α21 − α1ρ1 + α2ρ1) (B.4)
or
α2ρ
2
1
(
α21 + ρ1(α2 + α3)
)
+ α31ρ
2
2
α1ρ1
> α1ρ2 (αT − ρ1) + α2ρ1(ρ1 + ρ2), (B.5)
where αT =
∑3
i=1 αi.435
Appendix B.2. Model A2
We recall the model from Section 3.2.2. We obtained in Eq. (29) the steady
states PA2i for i = 1, 2, 3.
We use the Routh-Hurwitz Criterion to study the stability of PA23 . We
obtain the characteristic equation
λ3 + b2λ
2 + b1λ+ b0 = 0, (B.6)
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where
b2 =
(α2α3(α2 + α3)ρ
2
1 + α1 ρ1(α
2
2ρ1 + α2α3(3ρ1 − 2ρ2)
ρ1β
+ (B.7a)
+
α23(ρ1 − ρ2))− α21( α3(ρ1 − ρ2)ρ2 + α2ρ1(α3 + ρ2))
ρ1β
,
b1 =
α3
(
α22α3ρ
3
1 + 2α1α2ρ
2
1(α2ρ1 + α3(ρ1 − ρ2))− α31ρ1(ρ1 − ρ2)(α2 + ρ2)
)
ρ21β
+
(B.7b)
+
α3α
4
1(ρ1 − ρ2)ρ2
ρ21β
− α3α
2
1ρ1(α
2
2ρ1 + α3(ρ1 − ρ2)ρ2 + α2ρ1(α3 − ρ1 + 2ρ2))
ρ21β
,
b0 =
α1α3(α1 − ρ1)(α1ρ2 − α2ρ1)
ρ21
. (B.7c)
Positivity conditions for PA23 as in Eq. (35) and in Eq. (36) yield b0 > 0.
Finally, stability conditions b2 > 0 and b2b1 − b0 > 0 result in
(α2α3(α2 + α3)ρ
2
1 + α1 ρ1(α
2
2ρ1 + α2α3(3ρ1 − 2ρ2)
ρ1β
+
+
α23(ρ1 − ρ2))− α21(α3(ρ1 − ρ2)ρ2 + α2ρ1(α3 + ρ2))
ρ1β
> 0 (B.8a)
and
(r1ρ
2
1 + r2ρ1 + r3(ρ1 − ρ2))(r4ρ31 + r5ρ21 + r6(ρ1 − ρ2)))
β3
+
+ α1(ρ1 − α1)ρ21(α1ρ2 − α2ρ1) > 0 (B.8b)
where
r1 = α1α
2
2 + 3α1α2α3 + α2α3(α2 + α3),
r2 = −(α21α2 + 2α1α2α3)ρ2 − α21α2α3,
r3 = α1α3(α3ρ1 − α1ρ2),
r4 = α
2
1α2 + 2α1α
2
2 + α
2
2α3, (B.8c)
r5 = −α21α22 − α21α2α3 − 2α21α2ρ2,
r6 = 2α1α2α3ρ
2
1 + α
4
1ρ2 − ρ1α21(α1α2 + ρ2(α1 + α3)).
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Appendix C. Stability analysis for models B
Appendix C.1. Model B1440
Let us consider Eqs. (8) with last stage signalling sα = s1(t) as in Eq. (4),
this is, N = C3. The steady states for this model are
PB11 = (0, 0, 0), (C.1a)
PB12 =
(
0,
α3(α2 − ρ2)
kα2ρ2
,
α2 − ρ2
kρ2
)
, (C.1b)
PB13 =
(
α3(α1 − ρ1)(α2ρ1 − α1ρ2)
kα1α2ρ21
,
α3(α1 − ρ1)
kα2ρ1
,
α1 − ρ1
kρ1
)
. (C.1c)
The Jacobian matrix is JB1(C1, C2, C3) = JB1 such that
JB1 =

ρ1 − α1
C3k + 1
0
α1C1k
(C3k + 1)2
α1
C3k + 1
ρ2 − α2
C3k + 1
α2C2k − α1C1k
(C3k + 1)2
0
α2
C3k + 1
−α2C2k + α3
(C3k + 1)2

. (C.2)
Substituting PB1i for i = 1, 2, 3 in Eq. (C.2) we obtain the eigenvalues governing
linear stability. First, for PB11 , we obtain the same eigenvalues as for P
A1
1 , i.e.
λB11,1 = −α3, (C.3a)
λB11,2 = ρ1 − α1, (C.3b)
λB11,3 = ρ2 − α2. (C.3c)
For PB12 we get
λB12,1 = ρ1 −
α1ρ2
α2
, (C.4a)
λB12,2 = −
α3ρ2 +
√
α3ρ2
√
4α2 + α3 − 4ρ2
2α2
, (C.4b)
λB12,3 =
α3ρ2 −√α3ρ2
√
4α2 + α3 − 4ρ2
2α2
. (C.4c)
Finally, for PB13 , we obtain the characteristic equation
λ3 + b2λ
2 + b1λ+ b0 = 0, (C.5)
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where
b2 =
α2ρ1 + α3ρ1 − α1ρ2
α1
, (C.6a)
b1 =
α3ρ1(α2ρ1 + ρ2(ρ1 − 2α1))
α21
, (C.6b)
b0 =
α3(α1 − ρ1)ρ21(α1ρ2 − α2ρ1)
α31
. (C.6c)
Considering positivity conditions for PB12 and P
B1
3 , we find that λ
B1
1,i < 0 for
i = 1, 2, 3, and therefore PB11 is always stable. From the positivity conditions
we also get
ρ1
ρ2
>
α1
α2
. (C.7a)
which implies λB12,1 > 0 and therefore P
B1
2 is unstable.
Stability of this equilibrium PB13 can be analysed by the Routh-Hurwitz
Criterion from Eq. (B.3). However, given its own positivity conditions, we get445
b0 < 0, implying P
B1
3 is always unstable.
Appendix C.2. Model B2
Let us now consider Eqs. (8) with signalling coming from all cellular com-
partments sα = s1(t) as in Eq. (5), this is, N =
∑3
i=1 Ci. The steady states of
the model are
PB21 = (0, 0, 0), (C.8a)
PB22 =
(
0,
α3(α2 − ρ2)
k(α2 + α3)ρ2
,
α2(α2 − ρ2)
k(α2 + α3)ρ2
)
, (C.8b)
PB23 =
(
α3(α1 − ρ1)(α2ρ1 − α1ρ2)
ρ1kβ
,
α1α3(α1 − ρ1)
kβ
,
α1α2(α1 − ρ1)
kβ
)
, (C.8c)
where
β = (α2α3ρ1 + α1(α2ρ1 + α3(ρ1 − ρ2))) . (C.9)
The Jacobian matrix of Eqs. (8) with signal s given by Eq. (5) is JB2 =
JB2(C1, C2, C3) such that
JB2 = s
2

C1kα1 − α1
s
+
ρ1
s2
C1kα1 C1kα1
α1 + kR1 kR2 − α2
s
+
ρ2
s2
kR2
kR3 α2 + kR4 −α3 − kR5
 , (C.10)
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where
R1 = C2(α1 + α2) + C3α1, (C.11a)
R2 = C2α2 − C1α1, (C.11b)
R3 = C3α3 − C2α2, (C.11c)
R4 = C1α2 + C3(α2 + α3), (C.11d)
R5 = C1α3 + C2(α2 + α3). (C.11e)
Substituting PB2i for i = 1, 2, 3 in Eq. (C.10) we obtain the eigenvalues govern-
ing the linear stability. Specifically, for PB21 , we again get
λB21,1 = −α3, (C.12a)
λB21,2 = ρ1 − α1, (C.12b)
λB21,3 = ρ2 − α2. (C.12c)
For PB22 , we get the eigenvalues
λB22,1 = ρ1 −
α1ρ2
α2
, (C.13a)
λB22,2 = −
α23ρ2 + α3ρ
2
2 + h
∗(α2, α3, ρ2)
2α2(α2 + α3)
, (C.13b)
λB12,3 =
−α23ρ2 − α3ρ22 + h∗(α2, α3, ρ2)
2α2(α2 + α3)
. (C.13c)
where h∗ = h∗(α2, α3, ρ2) such that
h∗ =
√
α3ρ2
√
4α2(α22 + α2(2α3 − ρ2) + α3(α3 − 2ρ2)) + α3(α3 − ρ2)2. (C.14)
Finally, for PB23 , we obtain the characteristic equation
λ3 + b2λ
2 + b1λ+ b0 = 0, (C.15)
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where
b2 =
α2α3ρ
2
1(α2 + α3 + ρ1) + α1ρ1(α
2
2ρ1 + α2α3(ρ1 − 2ρ2)
α1β
+ (C.16a)
+
α23(ρ1 − ρ2))− α21(α2ρ1 + α3(ρ1 − ρ2))ρ2
α1β
,
b1 =
α3ρ1(α2ρ
2
1(α3ρ1 + α2(α3 + ρ1)) + α
3
1(ρ1 − ρ2)ρ2
α21β
+ (C.16b)
− α1α2ρ1(ρ
2
1 − 2α3ρ2 − ρ1ρ2)− α21(α2ρ21 + (α3 + ρ1)(ρ1 − ρ2)ρ2)
α21β
,
b0 =
α3(α1 − ρ1)ρ21(α1ρ2 − α2ρ1)
α31
. (C.16c)
Every equilibrium stability is influenced by the positivity conditions of the
other points. From the positivity of PB22 , we get that
α2 > ρ2. (C.17)
Two different scenarios arise from the positivity conditions of PB23 ; either
β > 0, (C.18a)
α1 > ρ1, (C.18b)
α2ρ1 > α1ρ2; (C.18c)
or
β < 0, (C.19a)
α1 < ρ1, (C.19b)
α2ρ1 < α1ρ2. (C.19c)
Whenever Eq. (C.18) holds, equilibrium PB21 is stable (mainly α1 < ρ1, as
Eq.(C.17) is true whenever PB22 > 0). Moreover, equilibrium P
B2
2 would also
be stable whenever Eq. (C.19) holds and also
|R(h∗)| < α23ρ2 + α3ρ22 (C.20)
where h∗ is defined as in Eq. (C.14). However, the stability of PB21 and P
B2
2
is biologically uninteresting. Focusing on the non-trivial state, with the above
constraints Eq.(C.18) or Eq.(C.19) and the Routh-Hurtwitz criterion, we have450
b0 < 0. Therefore, P
B2
3 is positive but always unstable.
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Appendix D. Summary of stability conditions
We summarise in Table D.3 the conclusions of the mathematical analysis
regarding stability of the non-trivial state.
Steady Model A1 Model A2 Model B1 Model B2
State sρ = s1, sα = 1 sρ = s2, sα = 1 sρ = 1, sα = s1 sρ = 1, sα = s2
P j1 Unstable Unstable Stable Conditionally
stable
P j2 Unstable Conditionally Unstable Conditionally
stable stable
P j3 Conditionally Conditionally Unstable Unstable
Stable Stable
Table D.3: Steady-state stability for every model from Eq. (6) under conditions of positivity
of the non-trivial steady state. Index j stands for the four models considering the different
feedback regulations: A1 for cell proliferation regulation, all cell feedback; A2 for proliferation
regulation, late cell feedback; B1 for transition rate regulation, late cell feedback; and B2 for
transition rate regulation, all cell feedback.
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